US Bioservices Collaborates With MedImpact Direct to Support Hemophilia Patients
May 31, 2018
May 31, 2018
FRISCO, Texas, May 31 -- AmerisourceBergen, a provider of pharmaceutical products, issued the following news release:
US Bioservices, a specialty pharmacy and part of AmerisourceBergen, has contracted with MedImpact, an independent, trend-focused pharmacy benefit manager, to dispense specialty prescriptions under the MedImpact Direct Specialty(TM) program. Under the program, US Bioservices is incorporating the use of myCubixx(R) temperature-controlled product storage devices for hem . . .
US Bioservices, a specialty pharmacy and part of AmerisourceBergen, has contracted with MedImpact, an independent, trend-focused pharmacy benefit manager, to dispense specialty prescriptions under the MedImpact Direct Specialty(TM) program. Under the program, US Bioservices is incorporating the use of myCubixx(R) temperature-controlled product storage devices for hem . . .